A white-knuckle ride of open COVID drug discovery.

von Delft, Frank; Calmiano, Mark; Chodera, John; Griffen, Ed; Lee, Alpha; London, Nir; Matviuk, Tatiana; Perry, Ben; Robinson, Matt; von Delft, Annette

von Delft, Frank; Calmiano, Mark; Chodera, John; Griffen, Ed; Lee, Alpha; London, Nir; Matviuk, Tatiana; Perry, Ben; Robinson, Matt; von Delft, Annette.

Nature ; 594(7863): 330-332, 2021 06.

Article in En | MEDLINE | ID: mdl-34127864

Subject(s)

Antiviral Agents/analysis; COVID-19 Drug Treatment; Cooperative Behavior; Drug Discovery/methods; Drug Discovery/organization & administration; Drug Evaluation, Preclinical/methods; Open Access Publishing; Animals; Antiviral Agents/pharmacology; Antiviral Agents/therapeutic use; COVID-19/epidemiology; COVID-19/virology; Clinical Trials as Topic; Coronavirus 3C Proteases/antagonists & inhibitors; Coronavirus 3C Proteases/chemistry; Crowdsourcing; Crystallography, X-Ray/instrumentation; Drug Repositioning; Goals; Humans; International Cooperation; Israel/epidemiology; SARS-CoV-2/genetics; SARS-CoV-2/isolation & purification; Social Media; Synchrotrons; Time Factors; United Kingdom/epidemiology; Videoconferencing; Volunteers; World Health Organization/organization & administration

Key words

Drug discovery; Medical research; Research management; SARS-CoV-2

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Cooperative Behavior / Drug Evaluation, Preclinical / Drug Discovery / Open Access Publishing / COVID-19 Drug Treatment Limits: Animals / Humans Country/Region as subject: Asia / Europa Language: En Journal: Nature Year: 2021 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google